Crispr Therapeutics Ag (CRSP)

R&D Expense Growth

-17.25%

Fiscal year · Period ending:

CRSP logo

CRSP R&D Expense Growth

Latest reported-17.25%
CRSP FY R&D Growth (YoY) (0.00% → -17.25%)
High-resolution chart · PNG

CRSP r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
-17.2542%
-17.2149%
-16.0974%
35.5519%
53.8368%
23.4275%
57.649%
62.9986%
65.254%
235.9421%
730.998%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.